A study to investigate use of off-the-shelf natural killer (NK) cells (SAR445419) in relapsed/refractory acute myeloid leukemia

Trial Identifier: TED17749
Sponsor: Sanofi
Start Date: June 2023
Primary Completion Date: February 2024
Study Completion Date: March 2024
Condition: Leukemia

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
UNITED STATES, Nebraska Omaha, Nebraska, UNITED STATES, 68198-2168
UNITED STATES, New York Bronx, New York, UNITED STATES, 10461
UNITED STATES, Texas Houston, Texas, UNITED STATES, 77030